Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults

Study of the Plasmodium Vivax Transmission-blocking Vaccine Pvs230D1-EPA/Matrix-M to Assess Safety, Immunogenicity, and Transmission-blocking Activity in Healthy Malaria-naive Adults

NCT05913973 ·Status: COMPLETED ·Phase: PHASE1

VAC077: Safety and Immunogenicity of the Pfs25-IMX313/Matrix-M Vaccine

NCT04130282 ·Status: TERMINATED ·Phase: PHASE1

Safety and Protective Efficacy of Genetically Attenuated PfSPZ-GA1 Vaccine in Healthy Dutch Volunteers

NCT03163121 ·Status: COMPLETED ·Phase: PHASE1

Experimental PfSPZ Vaccine in Adults Without Malaria

NCT01441167 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to a Malaria Vaccine (MSP1 42-C1) With or Without CPG 7909 Adjuvant

NCT00320658 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

NCT05581641 ·Status: COMPLETED ·Phase: PHASE1

Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine

NCT01867463 ·Status: COMPLETED ·Phase: PHASE1

Experimental Vaccine for Plasmodium Falciparum Malaria

NCT00340431 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Plasmodium Falciparum Malaria Vaccine Candidate Pfs48/45 in Matrix-M Adjuvant in the UK

NCT05400746 ·Status: TERMINATED ·Phase: EARLY_PHASE1

Phase I Study of AMA1-C1/Alhydrogel® (Registered Trademark) + CPG 7909 Malaria Vaccine

NCT00427167 ·Status: COMPLETED ·Phase: PHASE1

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

NCT06607003 ·Status: RECRUITING ·Phase: PHASE1

Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers

NCT04739917 ·Status: UNKNOWN ·Phase: PHASE2

Spatial Repellents for Vector Control

NCT04795648 ·Status: COMPLETED ·Phase: NA

Assessing Human-to-Mosquito Transmission in Volunteers Participating in Malaria Vaccine Candidate Trials in Mali

NCT02206451 ·Status: COMPLETED

Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali

NCT02334462 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Experimental Malaria Vaccines RH5.2-VLP and R21

NCT05357560 ·Status: COMPLETED ·Phase: PHASE1

Preventing the Spread of Malaria in Mali

NCT01360112 ·Status: COMPLETED

PpPfs25/ISA51 and ScPvs25/ISA51 Vaccines for Malaria

NCT00295581 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria

NCT00984763 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Trial of a Falciparum Malaria Protein (FMP012), E. Coli-expressed PfCelTOS, in Healthy Malaria-Naive Adults

NCT01540474 ·Status: COMPLETED ·Phase: PHASE1

Study of Controlled Human Malaria Infections to Evaluate Protection After Intravenous or Intramuscular Administration of PfSPZ Vaccine in Malaria-Naive Adults

NCT02015091 ·Status: COMPLETED ·Phase: PHASE1

Trial to Assess the Efficacy of Malaria Vaccine PfCS 102

NCT01031524 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Clinical Trial of the PfSPZ Vaccine

NCT01001650 ·Status: COMPLETED ·Phase: PHASE1

ICC-1132 - Candidate Vaccine Against P Falciparum Malaria

NCT00587249 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Immunogenicity, Tolerability and Safety of a Malaria Vaccine and Also Its Protective Efficacy in a Malaria Challenge Model

NCT01397227 ·Status: COMPLETED ·Phase: PHASE1/PHASE2